Relationship of Cystatin C With the Pathophysiology of CNS Diseases

１） Abrahamson M, Grubb A, Olafsson I, Lundwall A. Molecular cloning and sequence analysis

of cDNA coding for the precursor of the human

cysteine proteinase inhibitor cystatin C. FEBS Lett

1987;216:229-33. doi:10.1016/0014-5793（87）

80695-6.

２） Barrett AJ, Davies ME, Grubb A. The place

of human gamma-trace（cystatin C）amongst the

cysteine proteinase inhibitors. Biochem Biophys

Rres Com 1984;120:631-6. doi:10.1016/0006291x（84）91302-0.

３） Hansson SF, Simonsen AH, Zetterberg H, et

al. Cystatin C in cerebrospinal fluid and multiple

sclerosis. Ann Neurol 2007;62:193-6,discussion

205. doi:10.1002/ana.20945.

４） Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C.

Crit Rev Clin Lab Sci 2 0 0 4;4 1:4 6 7-5 5 0.

doi:10.1080/10408360490504934.

５）Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin

Nephrol 1992;38 Suppl 1:S20-7.

６）Abrahamson M, Olafsson I, Palsdottir A, et al.

Structure and expression of the human cystatin C

gene. Biochem J 1990;268:287-94. doi:10.1042/

bj2680287.

７） Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells.

Scand J Clin Lab Invest 1 9 9 5;5 5:6 1 7-2 3.

doi:10.3109/00365519509110261.

８） Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and

aortic aneurysms. J Clin Invest 1999;104:1191-7.

doi:10.1172/JCI7709.

９） Warfel AH, Zucker-Franklin D, Frangione

B, Ghiso J. Constitutive secretion of cystatin

C （gamma-trace） by monocytes and macrophages and its downregulation after stimulation. J Exp Med 1987;166:1912-7. doi:10.1084/

jem.166.6.1912.

10） Tu GF, Aldred AR, Southwell BR, Schreiber

G. Strong conservation of the expression of cystatin C gene in choroid plexus. Am J Physiol

1 9 9 2;2 6 3（1 Pt 2） :R1 9 5-2 0 0. doi:1 0.1 1 5 2/

ajpregu.1992.263.1.R195.

11） Yasuhara O, Hanai K, Ohkubo I, Sasaki M,

McGeer PL, Kimura H. Expression of cystatin

C in rat, monkey and human brains. Brain Res

1993;628:85-92. doi:10.1016/0006-8993（93）

90941-f.

12）Lignelid H, Collins VP, Jacobsson B. Cystatin

C and transthyretin expression in normal and

neoplastic tissues of the human brain and pituitary. Acta Neuropathol（Berl）1997;93:494-500.

doi:10.1007/s004010050644.

1 3） Umegae N, Nagai A, Terashima M, et al.

Cystatin C expression in ischemic white matter lesions. Acta Neurol Scand 2008;118:60-7.

doi:10.1111/j.1600-0404.2007.00984.x.

14） Sloane BF, Moin K, Krepela E, Rozhin J.

Cathepsin B and its endogenous inhibitors: the

role in tumor malignancy. Cancer Metastasis Rev

1990;9:333-52. doi:10.1007/bf00049523.

15） Taupin P, Ray J, Fischer WH, et al. FGF2-responsive neural stem cell proliferation requires

CCg, a novel autocrine/paracrine cofactor. Neuron

2000;28:385-97. doi:10.1016/s0896-6273（00）

00119-7.

1 6） Afonso S, Romagnano L, Babiarz B. The

expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development

1997;124:3415-25.

17） Gudmundsson G, Hallgrimsson J, TA J, Bjarnason O. Hereditary cerebral haemorrhage with

amyloidosis. Brain 1972;95:387-404. doi:10.1093/

brain/95.2.387.

18）Mandybur TI. Cerebral amyloid angiopathy: the

vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.

19） Nagai A, Terashima M, Sheikh AM, et al.

Involvement of cystatin C in pathophysiology

of CNS diseases. Front Biosci 2008;13:3470-9.

doi:10.2741/2941.

20） Cohen DH, Feiner H, Jensson O, Frangione

B. Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis （HCHWA） is related to

the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med 1983;158:623-8.

doi:10.1084/jem.158.2.623.

Cystatin C in CNS diseases

21）Ghiso J, Pons-Estel B, Frangione B. Hereditary

cerebral amyloid angiopathy: the amyloid fibrils

contain a protein which is a variant of cystatin

C, an inhibitor of lysosomal cysteine proteases.

Biochem Biophys Res Commun 1986;136:548-54.

doi:10.1016/0006-291x（86）90475-4.

22）Nagai A, Kobayashi S, Shimode K, et al. No

mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition. Mol

Chem Neuropathol 1998;33:63-78. doi:10.1007/

bf02815860.

23） Haan J, Maat-Schieman ML, van Duinen SG,

Jensson O, Thorsteinsson L, Roos RA. Co-localization of beta/A4 and cystatin C in cortical blood

vessels in Dutch, but not in Icelandic hereditary

cerebral hemorrhage with amyloidosis. Acta Neurol Scand 1994;89:367-71. doi:10.1111/j.16000404.1994.tb02648.x.

2 4） Itoh Y, Yamada M, Hayakawa M, Otomo

E, Miyatake T. Cerebral amyloid angiopathy: a

significant cause of cerebellar as well as lobar

cerebral hemorrhage in the elderly. J Neurol Sci

1993;116:135-41. doi:10.1016/0022-510x（93）

90317-r.

25） Maruyama K, Ikeda S, Ishihara T, Allsop D,

Yanagisawa N. Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied

cases using antibodies to beta protein and cystatin C. Stroke 1990;21:397-403. doi:10.1161/01.

str.21.3.397.

2 6 ） Vinters HV, Nishimura GS, Secor DL,

Pardridge WM. Immunoreactive A4 and gammatrace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's

disease. Am J pathol 1990;137:233-40.

27）Izumihara A, Ishihara T, Hoshii Y, Ito H. Cerebral amyloid angiopathy associated with hemorrhage: immunohistochemical study of 41 biopsy

cases. Neurol Med Chir（Tokyo）2001;41:471-7,

discussion 477-8. doi:10.2176/nmc.41.471.

28） Jormsjo S, Wuttge DM, Sirsjo A, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in

apolipoprotein E-deficient mice. Am J Pathol

2002;161:939-45. doi:10.1016/S0002-9440（10）

64254-X.

29） Sukhova GK, Shi GP, Simon DI, Chapman

HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation

of their production in smooth muscle cells. J Clin

Invest 1998;102:576-83. doi:10.1172/JCI181.

30）Abdul-Hussien H, Soekhoe RG, Weber E, et al.

Collagen degradation in the abdominal aneurysm:

a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 2007;170:809-17.

doi:10.2353/ajpath.2007.060522.

31） Bjarnadottir M, Nilsson C, Lindstrom V, et

al. The cerebral hemorrhage-producing cystatin C

variant （L68Q） in extracellular fluids. Amyloid

2001;8:1-10. doi:10.3109/13506120108993809.

32）Maruyama K, Kametani F, Ikeda S, Ishihara T,

Yanagisawa N. Characterization of amyloid fibril

protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for

both beta protein and cystatin C. Neurosci Lett

1992;144:38-42. doi:10.1016/0304-3940（92）

90710-o.

3 3） Janowski R, Kozak M, Jankowska E, et

al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001;8:316-20.

doi:10.1038/86188.

34） Jaskolski M. 3D domain swapping, protein

oligomerization, and amyloid formation. Acta Biochim Pol 2001;48:807-27.

35）Abrahamson M, Mason RW, Hansson H, Buttle

DJ, Grubb A, Ohlsson K. Human cystatin C. role

of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by

leucocyte elastase. Biochem J 1991;273 （Pt 3）

:621-6. doi:10.1042/bj2730621.

36）Barrett AJ, Fritz H, Grubb A, et al. Nomenclature and classification of the proteins homologous

with the cysteine-proteinase inhibitor chicken cystatin [letter]. Biochem J 1986;236:312.

37）Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin

Nephrol 1992;38（Suppl 1）:S20-7.

38） Assfalg-Machleidt I, Billing A, Frohlich D, et

al. The role of the kininogens as cysteine proteinase inhibitors in local and systemic inflammation.

Agents Actions Suppl 1992; 8（Pt 1）:12-21.

39）Lenarcic B, Gabrijelcic D, Rozman B, DrobnicKosorok M, Turk V. Human cathepsin B and cys-

10

NAGAI

teine proteinase inhibitors（CPIs）in inflammatory

and metabolic joint diseases. Biol Chem Hoppe

Seyler 1988;369 Suppl:257-61.

40） Lah TT, Babnik J, Schiffmann E, Turk V,

Skaleric U. Cysteine proteinases and inhibitors in

inflammation: their role in periodontal disease. J

Periodontol 1993;64（5 Suppl）:485-91.

41） Buttle DJ, Burnett D, Abrahamson M. Levels

of neutrophil elastase and cathepsin B activities,

and cystatins in human sputum: relationship to inflammation. Scand J Clin Lab Invest 1990;50:50916. doi:10.1080/00365519009089165.

42）Chapman HA, Jr., Reilly JJ, Jr., Yee R, Grubb

A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of

human alveolar macrophages in vitro. Am Rev

Respir Dis 1990;141:698-705. doi:10.1164/ajrccm/141.3.698.

43） Nagai A, Murakawa Y, Terashima M, et al.

Cystatin C and cathepsin B in CSF from patients

with inflammatory neurologic diseases. Neurology

2000;55:1828-32. doi:10.1212/wnl.55.12.1828.

44） Nagai A, Terashima M, Harada T, et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients

with leptomeningeal metastasis. Clin Chim Acta

2003;329:53-60. doi:10.1016/s0009-8981（03）

00023-8.

45） Okamoto K, Hirai S, Amari M, Watanabe M,

Sakurai A. Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anticystatin C serum. Neurosci Lett 1993;162:125-8.

doi:10.1016/0304-3940（93）90576-7.

46）van Welsem ME, Hogenhuis JA, Meininger V,

Metsaars WP, Hauw JJ, Seilhean D. The relationship between Bunina bodies, skein-like inclusions

and neuronal loss in amyotrophic lateral sclerosis. Acta Neuropathol （Berl） 2002;103:583-9.

doi:10.1007/s00401-001-0507-3.

47）Ranganathan S, Williams E, Ganchev P, et al.

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J

Neurochem 2005;95:1461-71. doi:10.1111/j.14714159.2005.03478.x.

48）Asgeirsson B, Haebel S, Thorsteinsson L, et al.

Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin

C variant in cerebrospinal fluids and monocyte

cultures by MS. Biochem J 1998;329 （Pt 3）

:497-503. doi:10.1042/bj3290497.

49） Wei L, Berman Y, Castano EM, et al. Instability of the amyloidogenic cystatin C variant of

hereditary cerebral hemorrhage with amyloidosis,

Icelandic type. J Biol Chem 1998;273:11806-14.

doi:10.1074/jbc.273.19.11806.

50） Palm DE, Knuckey NW, Primiano MJ, Spangenberger AG, Johanson CE. Cystatin C, a protease inhibitor, in degenerating rat hippocampal

neurons following transient forebrain ischemia.

Brain Res 1995;691:1-8. doi:10.1016/0006-8993

（95）00520-z.

51） Lee DC, Close FT, Goodman CB, et al. Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure.

Neurotoxicology 2006;27:260-76. doi:10.1016/

j.neuro.2005.11.011.

5 2） Nishio C, Yoshida K, Nishiyama K, Hatanaka H, Yamada M. Involvement of cystatin C

in oxidative stress-induced apoptosis of cultured

rat CNS neurons. Brain Res 2000;873:252-62.

doi:10.1016/s0006-8993（00）02540-3.

53） Nagai A, Suzuki Y, Baek SY, et al. Generation and characterization of human hybrid neurons

produced between embryonic CNS neurons and

neuroblastoma cells. Neurobiol Dis 2002;11:18498. doi:10.1006/nbdi.2002.0501.

54） Nagai A, Ryu JK, Terashima M, et al. Neuronal cell death induced by cystatin C in vivo

and in cultured human CNS neurons is inhibited

with cathepsin B. Brain Res 2005;1066:120-8.

doi:10.1016/j.brainres.2005.10.063.

55） Liang X, Nagai A, Terashima M, et al. Cystatin C induces apoptosis and tyrosine hydroxylase

gene expression through JNK-dependent pathway

in neuronal cells. Neurosci lett 2011;496:100-5.

doi:10.1016/j.neulet.2011.03.091.

56）Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in

the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001;60:94-104. doi:10.1093/

jnen/60.1.94.

57） Cataldo AM, Thayer CY, Bird ED, Wheelock

TR, Nixon RA. Lysosomal proteinase antigens

are prominently localized within senile plaques of

Cystatin C in CNS diseases

Alzheimer's disease: evidence for a neuronal origin. Brain Res 1990;513:81-92. doi:10.1016/00068993（90）91091-t.

58） Cataldo AM, Barnett JL, Berman SA, et al.

Gene expression and cellular content of cathepsin

D in Alzheimer's disease brain: evidence for early

up-regulation of the endosomal-lysosomal system.

Neuron 1995;14:671-80. doi:10.1016/0896-6273

（95）90324-0.

59） Deng A, Irizarry MC, Nitsch RM, Growdon

JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J

Pathol 2001;159:1061-8. doi:10.1016/S0002-9440

（10）61781-6.

60）Balbin M, Grubb A, Abrahamson M. An Ala/

Thr variation in the coding region of the human cystatin C gene （CST3） detected as a

SstII polymorphism. Hum Genet 1993;92:206-7.

doi:10.1007/bf00219694.

61）Beyer K, Lao JI, Gomez M, et al. Alzheimer's

disease and the cystatin C gene polymorphism: an

association study. Neurosci Lett 2001;315:17-20.

doi:10.1016/s0304-3940（01）02307-2.

6 2） Finckh U, von der Kammer H, Velden J,

et al. Genetic association of a cystatin C gene

polymorphism with late-onset Alzheimer disease.

Arch Neurol 2000;57:1579-83. doi:10.1001/arch-

11

neur.57.11.1579.

63）Crawford FC, Freeman MJ, Schinka JA, et al.

A polymorphism in the cystatin C gene is a novel

risk factor for late-onset Alzheimer's disease. Neurology 2000;55:763-8. doi:10.1212/wnl.55.6.763.

64） Cathcart HM, Huang R, Lanham IS, Corder

EH, Poduslo SE. Cystatin C as a risk factor for

Alzheimer disease. Neurology 2005;64:755-7.

doi:10.1212/01.WNL.0000151980.42337.44.

65） Monastero R, Camarda C, Cefalu AB, et al.

No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control

study in an Italian population. J Alzheimers Dis

2005;7:291-5. doi:10.3233/jad-2005-7404.

66） Maruyama H, Izumi Y, Oda M, et al. Lack

of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's

disease. Neurology 2001;57:337-9. doi:10.1212/

wnl.57.2.337.

67） Wada Y, Nagai A, Sheikh AM, et al. Colocalization of cystatin C and prosaposin in

cultured neurons and in anterior horn neurons

with amyotrophic lateral sclerosis. J Neurol Sci

2018;384:67-74. doi:10.1016/j.jns.2017.11.023.

68）Barrett AJ, Kirschke H. Cathepsin B, cathepsin

H, and cathepsin L. Methods Enzymol 1981;80

（Pt C） :535-61. doi:10.1016/s0076-6879（81）

80043-2.

...